These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 2898096

  • 41. Mifepristone as a therapeutic agent in psychiatry.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2013 Jun; 51(6):11-4. PubMed ID: 23814820
    [Abstract] [Full Text] [Related]

  • 42. Hypothalamic-pituitary-adrenal axis.
    Honour JW.
    Respir Med; 1994 Aug; 88 Suppl A():9-13; discussion 13-5. PubMed ID: 7972994
    [No Abstract] [Full Text] [Related]

  • 43. Role of serotonin in hypothalamo pituitary adrenal axis escape from dexamethasone suppression.
    Krishnan KR, Ritchie JC, Manepalli AN, Wilson WH, Saunders WB, Venkataraman SS, Carroll BJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Aug; 15(5):637-42. PubMed ID: 1659724
    [Abstract] [Full Text] [Related]

  • 44. Reversal of non-suppression of cortisol levels in a patient with refractory depression receiving ketamine.
    Ostroff R, Kothari JS.
    Am J Psychiatry; 2015 Jan; 172(1):95-6. PubMed ID: 25553498
    [No Abstract] [Full Text] [Related]

  • 45. Does the dexamethasone suppression test reliably discriminate between psychotic and nonpsychotic major depression?: an exploratory analysis of potential confounds.
    Gaudiano BA, Epstein-Lubow G, Miller IW.
    J Nerv Ment Dis; 2009 Jun; 197(6):395-400. PubMed ID: 19525738
    [Abstract] [Full Text] [Related]

  • 46. Comparisons of the costs of psychotropic medications: an update.
    Jurman RJ, Davis JM.
    Psychiatr Med; 1991 Jun; 9(2):349-59. PubMed ID: 1677482
    [Abstract] [Full Text] [Related]

  • 47. [Stress and psychosis].
    Halsband SA.
    Vertex; 2002 Jun; 13 Suppl 1():12-6. PubMed ID: 12122422
    [Abstract] [Full Text] [Related]

  • 48. The potential role of a corticotropin-releasing factor receptor-1 antagonist in psychiatric disorders.
    Stahl SM, Wise DD.
    CNS Spectr; 2008 Jun; 13(6):467-83. PubMed ID: 18567971
    [No Abstract] [Full Text] [Related]

  • 49. Hypothalamic-pituitary-adrenal axis suppression related to topical glucocorticoid therapy in a child with psoriatic exfoliative erythroderma.
    Campbell LS, Chevalier M, Levy RA, Rhodes A.
    Pediatr Dermatol; 2012 Jun; 29(1):101-4. PubMed ID: 21995486
    [Abstract] [Full Text] [Related]

  • 50. [Psychopharmaco-endocrinology and depression research].
    Laakmann G.
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1988 Jun; 46():1-220. PubMed ID: 2831451
    [No Abstract] [Full Text] [Related]

  • 51. [Endocrinologic adverse effects of psychotropic drugs].
    Elenitza IM.
    Vertex; 2005 Jun; 16(59):43-8. PubMed ID: 15785788
    [Abstract] [Full Text] [Related]

  • 52. Human studies on the biological basis of reinforcement. A neuroendocrine perspective.
    Mendelson JH, Mello NK, Teoh SK, Lukas SE, Phipps W, Ellingboe J, Palmieri SL, Schiff I.
    Res Publ Assoc Res Nerv Ment Dis; 1992 Jun; 70():131-55. PubMed ID: 1535928
    [No Abstract] [Full Text] [Related]

  • 53. Psychotropic Drug Effects on Steroid Stress Hormone Release and Possible Mechanisms Involved.
    Romanova Z, Hlavacova N, Jezova D.
    Int J Mol Sci; 2022 Jan 14; 23(2):. PubMed ID: 35055090
    [Abstract] [Full Text] [Related]

  • 54. Hypothalamic-pituitary-adrenal regulation, neurotransmitters and affective disorders.
    Janowsky DS, Risch SC, Huey LY, Judd LL, Rausch JL.
    Peptides; 1983 Jan 14; 4(5):775-84. PubMed ID: 6140674
    [Abstract] [Full Text] [Related]

  • 55. Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity.
    Holsboer F.
    Eur Arch Psychiatry Neurol Sci; 1989 Jan 14; 238(5-6):302-22. PubMed ID: 2670576
    [Abstract] [Full Text] [Related]

  • 56. Drugs and the DST: need for a reappraisal.
    Kraus RP, Grof P, Brown GM.
    Am J Psychiatry; 1988 Jun 14; 145(6):666-74. PubMed ID: 3285700
    [Abstract] [Full Text] [Related]

  • 57. Effectiveness of psychotropic drugs in patients in a state of malnutrition or exposed to extreme climatic conditions.
    Olatawura MO.
    Psychopharmacol Bull; 1977 Jan 14; 13(1):8-13. PubMed ID: 13454
    [No Abstract] [Full Text] [Related]

  • 58. Neuro-endocrine aspects of the dexamethasone suppression test in psychiatry.
    Lamberts SW.
    Life Sci; 1986 Jul 14; 39(2):91-5. PubMed ID: 3014253
    [No Abstract] [Full Text] [Related]

  • 59. Psychotropic medication effects on cortisol: Implications for research and mechanisms of drug action.
    Subramaniam A, LoPilato A, Walker EF.
    Schizophr Res; 2019 Nov 14; 213():6-14. PubMed ID: 31307858
    [Abstract] [Full Text] [Related]

  • 60. Effects of corticotropin on the thymus and the hypothalamo-pituitary-adrenal system.
    Guseinov SG, Aliev MG, Kurbanov TG.
    Neurosci Behav Physiol; 1983 Nov 14; 13(2):135-8. PubMed ID: 6318152
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.